Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are starting (neo)adjuvant chemotherapy for breast cancer under one of the following specific treatment plans: four cycles of doxorubicin and cyclophosphamide given every two weeks, followed by twelve weekly doses of paclitaxel (sometimes combined with carboplatin); or nine cycles of paclitaxel, carboplatin, trastuzumab, and pertuzumab given on a three-weekly schedule.
- People aged 18 years or older.
- People who are generally well enough to carry out light activity and care for themselves, with only minor limitations on physical activity (confirm with trial site).
- People who are able to use a digital health platform called EHP, or who have someone to help them use it, including being able to log in using DigiD (a Dutch government identity verification system).
- People who are able to read, or who have a family member or support person who can assist them if reading is difficult.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are already taking part in another clinical trial that involves an experimental treatment or product.
- People who have previously received chemotherapy at any point in the past.
- People who have already begun their current chemotherapy treatment cycle.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0031 72 5482872
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
The occurrence of any non-hematological side effects grade ≥3
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.